Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Summit Therapeutics Inc. (SMMT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
16 Aug 2022
Dhingra Ankur
Chief Financial Officer, Officer
Summit Therapeutics Inc.
(SMMT)
38,057
+1966%
36,215
$0.97
$35,128.55
BUY
16 Aug 2022
DUGGAN ROBERT W
Chief Executive Officer, Director, Officer
Summit Therapeutics Inc.
(SMMT)
162,532,800
+140%
94,849,200
$0.97
$92,003,730.00
BUY
16 Aug 2022
Zanganeh Maky
Co-CEO & President, Director, Officer
Summit Therapeutics Inc.
(SMMT)
359,969
+106%
5,809,132
$0.97
$5,634,858.00
BUY
12 May 2021
Zanganeh Maky
Chief Operating Officer, Director, Officer
Summit Therapeutics Inc.
(SMMT)
2,643,319
+17%
389,077
$5.24
$2,038,763.40
BUY
12 May 2021
DUGGAN ROBERT W
Chief Executive Officer, Director, Officer, 10% Owner
Summit Therapeutics Inc.
(SMMT)
67,662,456
+20%
11,365,921
$5.24
$59,557,424.00
SELL
27 Nov 2020
Powell David Jonathan
Chief Scientific Officer, Officer
Summit Therapeutics Inc.
(SMMT)
0
-100%
43,282
$4.41
$190,693.62
SELL
23 Nov 2020
Powell David Jonathan
Chief Scientific Officer, Officer
Summit Therapeutics Inc.
(SMMT)
0
-100%
30,431
$4.30
$130,769.75
BUY
6 Nov 2020
DUGGAN ROBERT W
Chief Executive Officer, Director, Officer, 10% Owner
Summit Therapeutics Inc.
(SMMT)
56,296,532
+33%
14,071,856
$3.34
$46,999,996.00
Home